Naltrexone Viatris (Naltrexone Hydrochloride)

Naltrexone works by competitively binding to mu‑opioid receptors in the brain without activating them. This blocks both endogenous opioids and external opioid drugs from stimulating the receptors, thereby diminishing the pleasurable sensations and cravings associated with alcohol and opioid use.

The specific dose of Naltrexone Viatris is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for naltrexone during pregnancy and lactation are limited. It is generally classified as a drug of unknown risk, and use is only recommended if the potential benefits outweigh any possible risks to the fetus or infant. Consultation with a healthcare provider is essential.

To order Naltrexone Viatris, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

The primary alternative to naltrexone is naloxone, which is a short‑acting opioid antagonist used mainly for emergency overdose reversal. Naltrexone has a longer duration of action and is used for maintenance therapy in dependence, whereas naloxone provides rapid, temporary blockade and is not intended for long‑term treatment.

Naltrexone Viatris should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its stability and potency throughout its shelf life.

Naltrexone Viatris is administered orally, typically as a tablet taken with water. The exact timing relative to meals or other medications should follow the prescribing clinician’s guidance to ensure optimal absorption and effectiveness.

Serious risks include hepatotoxicity, severe depression or suicidal thoughts, and allergic reactions such as rash or anaphylaxis. Patients should promptly report any signs of liver dysfunction, mood changes, or hypersensitivity to their healthcare provider.

Naltrexone Viatris is contraindicated in individuals with acute opioid withdrawal, those who are currently using opioid analgesics, and patients with known hypersensitivity to naltrexone or any of its excipients. Caution is also advised for patients with severe hepatic impairment.